US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
RLMD holding history
Relmada Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −7,950−100.0% | Sold out | Holders |
| Q3 2022 | 7,950 | $295.0K | <0.1% | +7,332+1,186.4% | Added | Holders |
| Q2 2022 | 618 | $12.0K | <0.1% | −97−13.6% | Reduced | Holders |
| Q1 2022 | 715 | $19.0K | <0.1% | +164+29.8% | Added | Holders |
| Q4 2021 | 551 | $12.0K | <0.1% | +523+1,867.9% | Added | Holders |
| Q3 2021 | 28 | $1.00K | <0.1% | +28 | New | Holders |